Board of Directors
Co-Founder, Director, Alta Partners
Mr. Gruener is a co-founder of Alta, and was also a Partner at Burr, Egan, Deleage & Co. He served as the Chief Executive Officer at Nanōmix from 2008 to 2013 and has more than two decades of experience in the fields of software development, systems engineering and corporate development. In 1982, he founded Virtual Microsystems, a successful communications software company that was later merged with a larger corporation. Garrett also founded Ask Jeeves, now Ask.Com, a leading Internet search engine which is now part of IAC. Garrett specializes in information technology and is on the board of directors of nCircle Network Security and Xelerated. He earned a Masters Degree from the University of California, Berkeley and a Bachelor of Science from the University of California, San Diego, both in Political Science with a focus on technology policy.
President and CEO, Nanōmix
Mr. Ludvigson is a financial and operating executive, and entrepreneur, with over 35 years of international experience in life sciences and technology companies including IDEC Pharmaceuticals, Matrix Pharmaceutical, Nanogen, and MIPS Computer Systems. He has over 20 years of Life Science experience including more than 15 years in the diagnostics arena and has led numerous new product efforts from concept to market launch. Mr. Ludvigson has concluded many successful strategic transactions including multiple acquisitions, corporate partnerships, technology and intellectual property licensing agreements, and OEM relationships and his financing experience includes venture capital, corporate, mezzanine, lease, bank credit line, LBO, IPO and secondary public sources. Mr. Ludvigson holds both a BA and MAS from the University of Illinois.
Marvin L. Cohen, Ph.D.
Professor Cohen is a preeminent figure in the field of theoretical con-
densed matter physics. He is a founding scientist of Nanōmix and also serves as a
Senior Scientist at the Lawrence Berkeley National Laboratory. He is a member of the
National Academy of Sciences, a member of the American Academy of Arts and
Sciences, a Fellow of the American Association for the Advancement of Science, a
Fellow of the American Physical Society, and the recipient of numerous scientific
awards, including the National Medal of Science and the Foresight Institute Feynman
Board Member, Audit Committee Chairperson
Chief Financial Officer of Stem Cells, Inc.
Mr. Schiffman is a CPA and an accomplished senior finance executive with more than 25 years of strategic and operational finance, treasury, corporate development and manufacturing operations experience. He has served as Chief Financial Officer at Iovance, as Executive Vice President and Chief Financial Officer at StemCells, Inc., Dendreon, and Affymetrix, all publicly-traded healthcare companies as well as Vineti a private SaaS company supporting supply chain requirements for cellular therapies. Notably, while serving as Executive Vice President and CFO of Dendreon Corporation, the company secured marketing authorization from the FDA and the European Commission for the world’s first cell-based, autologous immunotherapy for prostate cancer. Prior to these roles, he was Vice President and Controller at Applied BioSystems where he managed global financial operations and headed up a variety of global assignments at Hewlett Packard including international finance projects in Europe and Asia, and a U.S. manufacturing operation. He is on the board of directors of BioEclipse and DropCar. Mr. Schiffman received an M.B.A. from Northwestern University and holds a bachelor’s degree in accounting from De Paul University.
Alex Zettl, Ph.D.
Nanōmix Co-Founder; Professor, Department of Physics, University of
Professor Zettl is a founding scientist of Nanōmix Inc. and also leads the
Superconductivity and the sp2 Nanoscience Programs at the Lawrence Berkeley
National Laboratory. He is a renowned expert on condensed-matter experimental
physicists, and is a Fellow of the American Physical Society. Professor Zettl's primary
expertise is in the synthesis and characterization of novel materials and nanostructures.
Principal of Zygote Ventures
Mr. Fiddler is the principal of Zygote Ventures and has helped create and grow numerous companies, as CEO, chairman, director, investor and advisor. Mr. Fiddler is the founder of Wind River and was for 23 years its CEO and Chairman. He is currently the Chairman of Solazyme (Nasdaq:SZYM).